Mallinckrodt plc Ordinary Shares

Updates from The Motley Fool

Latest updates on Mallinckrodt from
2014's Most Shocking Takeover

Despite investigations into the composition of its key drug, Acthar gel, as well as into its mark...

Stock Performance

View Interactive MNK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Mallinckrodt.
Current Price: $63.97
Prev Close: $63.87
Open: $63.87
Bid: $63.94
Ask: $63.97
Day's Range: $63.72 - $64.77
52wk Range: $50.90 - $85.83
Volume: 738,652
Avg Vol 1,379,547
Market Cap: $7B
P/E (ttm): 13.88
EPS (ttm): $4.60
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Mallinckrodt.
CAPS Rating 2 out of 5
54 Outperform
13 Underperform
CAPS All Stars
10 Outperform
9 Underperform

How do you think Mallinckrodt will perform against the market?

You pick for Mallinckrodt is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark Trudeau, CEO

32% Approve

Based on 74 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Mallinckrodt.

Mallinckrodt plc Ordinary Shares

  • Exchange: NYSE